Advancing antibody development using AI for more effective disease targeting.
Role | Deep Tech Used | Impact Vector | Industry | Impact Vector %Benefit |
---|---|---|---|---|
CEO | Artificial Intelligence (AI), Biotechnology | Growth | Healthcare & Pharmaceuticals | 45% |
Advancing antibody development with AI improves disease targeting by analyzing vast biological data to design antibodies that bind more effectively to specific disease targets. This approach accelerates drug discovery, enhances treatment precision, and holds promise for more effective therapies against various diseases.
Request for Full Version